Equities

Star Health and Allied Insurance Company Ltd

STARHEALTH:NSI

Star Health and Allied Insurance Company Ltd

Actions
FinancialsLife Insurance
  • Price (INR)618.60
  • Today's Change12.60 / 2.08%
  • Shares traded1.04m
  • 1 Year change-0.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy7
Outperform5
Hold2
Sell3
Strong Sell2

Share price forecast in INR

The 20 analysts offering 12 month price targets for Star Health and Allied Insurnc Cmpny Ltd have a median target of 677.50, with a high estimate of 730.00 and a low estimate of 550.00. The median estimate represents a 9.64% increase from the last price of 617.95.
High18.1%730.00
Med9.6%677.50
Low-11.0%550.00

Earnings history & estimates in INR

On Jul 30, 2024, Star Health and Allied Insurnc Cmpny Ltd reported 1st quarter 2025 earnings of 5.36 per share.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+37.09%
Star Health and Allied Insurnc Cmpny Ltd reported annual 2024 earnings of 14.19 per share on Apr 30, 2024.
Average growth rate+36.31%
More ▼

Revenue history & estimates in INR

Star Health and Allied Insurnc Cmpny Ltd had 1st quarter 2025 revenues of 31.70bn. This missed the 35.26bn consensus estimate of the 2 analysts following the company. This was 13.19% above the prior year's 1st quarter results.
Average growth rate+7.46%
Star Health and Allied Insurnc Cmpny Ltd had revenues for the full year 2024 of 140.67bn. This was 14.19% above the prior year's results.
Average growth rate+15.19%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.